Healionics has developed a novel vascular graft, based on a platform biomaterial, offering improved vascular access for dialysis patients. Founded by Andrew J Marshall, Buddy Ratner, Max Maginness, and Michel Alvarez in 2007, Healionics is backed by investors that include Alliance of Angels, Keiretsu Forum, Rockies Venture Club, Tacoma Angel Network, and Tech Coast Angels and is headquartered in Seattle.